Veterinary Anti-infectives Market Size, Share and Global Trend By Animal Type (Livestock, Companion), By Drug Class (Antimicrobial Agents, Antiviral Agents, Antifungal Agents, Antiparasitic Agents), By Route of Administration (Oral, Parenteral, Topical) By End User (Veterinary Hospitals, Veterinary Clinics, Others) and Regional Forecast, 2024-2032
KEY MARKET INSIGHTS
In recent years, reports of deadly animal disease epidemics have become more frequent. These diseases are not only a threat to the existence of many wild species but also lead to substantial livestock losses. The prevention and treatment of such conditions are key market indicators for veterinary therapeutics, including veterinary anti-infectives.
According to World Organisation of Animal Health, foot and mouth disease (FMD) is a transboundary animal disease (TAD) that severely affects the production of livestock and disturbing regional and international trade in animals and animal products. The disease is estimated to affect an estimated 77% of the global livestock population, in Africa, the Middle East and Asia, as well as Latin America in 2019.
To gain extensive insights into the market, Request for Customization
Global veterinary anti-infectives market growth is been driven by the increasing prevalence of food-borne disease. According to a study published by National Center for Biotechnology Information, U.S. National Library of Medicine in 2017, in the United States an estimated 9.4 million cases of the food-borne disease were reported. Of these, 11% were caused by Salmonella and 9% by Campylobacter.
The increasing incidence of these diseases will subsequently increase the demand for the veterinary anti-infectives. Rise in pet ownership in the developed and developing countries combined with various initiatives taken by the government and private organizations of various countries have propelled the veterinary anti-infectives market growth.
On the flip side, existence counterfeit medicines, increasing costs of animal testing and veterinary services are restraining the growth of the global veterinary anti-infectives market.
Key Players Covered
The major companies covered in the global veterinary anti-infectives market report include Zoetis, Intervet Inc., Boehringer Ingelheim International GmbH, Ceva, Elanco, Vetoquinol S.A., Bayer AG, and others.
SEGMENTATION
SEGMENTATION | DETAILS |
By Animal Type | · Livestock · Companion |
By Drug Class | · Antimicrobial Agents · Antiviral Agents · Antifungal Agents · Antiparasitic Agents |
By Route of Administration | · Oral · Parenteral · Topical |
By End User | · Veterinary Hospitals · Veterinary Clinics · Others |
By Geography | · North America (the USA and Canada) · Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe) · Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific) · Latin America (Brazil, Mexico and Rest of Latin America) · Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa) |
As per the current veterinary anti-infectives market trends, antimicrobial agents among the drug class domintated the global veterinary anti-infectives market followed by the antiviral agents. Among the antimicrobial agents, penicillins, cephalosporins, and tetracyclines are projected to register a significantly higher growth rate during forecast period.
Key Insights
- Prevalence of Veterinary Food-borne disease
- New Product Launches
- Pipeline Analysis
- Key Mergers And Acquisitions
Regional Analysis
The global veterinary anti-infectives market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global veterinary anti-infectives market in 2018, followed by Europe. Asia-Pacific region is anticipated to grow at significant CAGR due to the trends, such as increasing awareness about animal care, and key market players focusing on distribution partnerships in India. The market in Middle East and Africa and Latin America is projected to grow at relatively lower CAGR during the forecast period.
Veterinary Anti-infectives Industry Developments
- In August 2018, Precision Health Technologies received master distributorship for Grazix’s natural animal health products in the North American region from Grazix Animal Health Incorporation and LiveLeaf Incorporation
- In April 2017, Zoetis completed the acquisition of Nexvet, a biologic therapeutics company developing a pipeline of monoclonal antibody therapies for companion animals in pain and other therapeutic areas.
- Ongoing
- 2023
- 2019-2022
-
Get in Touch with Us
-
US +1 833 909 2966 ( Toll Free )
-
